Ann: Kazia progress update, page-5

And I also additionally liked this bit:

“Of note, these shares have been issued at no discount, with no warrant coverage, and with transaction fees approximately half of those associated with traditional financing.”

So what that does tell is that despite some truly pathetic criticism of JG and his financial ability recently he is actually doing a very good job in an extremely challenging market (especially for biotech).